BACE1 and Alzheimer disease: Despite extensive research performed in several mouse models such as double transgenic mice (APP23 × PS45)—[107] or Tg2576 transgenic mice—[108], none of the major BACE1 inhibitors tested were documented to show behavioral effects in AD animal models.